EC Number   |
Title   |
Organism   |
|---|
 2.3.1.255 | A novel human NatA N<sup>±</sup>-terminal acetyltransferase complex: HNaa16p-hNaa10p (hNat2-hArd1) |
Homo sapiens |
 2.3.1.255 | A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly |
Homo sapiens |
 2.3.1.255 | A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy |
Homo sapiens |
 2.3.1.255 | Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis |
Mus musculus |
 2.3.1.255 | An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development |
Mus musculus |
 2.3.1.255 | ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity |
Saccharomyces cerevisiae |
 2.3.1.255 | Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation |
Homo sapiens |
 2.3.1.255 | Biochemical evidence for relaxed substrate specificity of Nalpha-acetyltransferase (Rv3420c/rimI) of Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
 2.3.1.255 | Biochemical evidence for relaxed substrate specificity of Nalpha-acetyltransferase (Rv3420c/rimI) of Mycobacterium tuberculosis |
Mycobacterium tuberculosis H37Rv |
 2.3.1.255 | Biochemical evidence for relaxed substrate specificity of Nalpha-acetyltransferase (Rv3420c/rimI) of Mycobacterium tuberculosis |
Mycobacterium tuberculosis ATCC 25618 |